These inflammatory cells are good candidates to be the main source of MMP-9 post-stroke in the setting of tPA treatment, and may be responsible, at least in part, for tPA-induced hemorrhage (Cuadrado et al., 2008). The gene discussed is PLAT; the disease is stroke disorder.